Re: New Stratton Cpn study

[Guest guest]

I contacted Wheldon about this study to ask about the lack of

metronidazole. He

said that the main purpose of this was to demonstrate that the reduction of Cpn

in

cerebrospinal fluid and the reduction in lesions in MS was not due to

anti-inflammatory

effects of the abx. Both these abx are considered to not have anti-inflam

effects. So this

was a scientific study, in part, to respond to critique and sort out those

variables. As an

indicator of how meticulous this whole line of research by Stratton, et al has

been, they

even used riboflavin in the placebo to make the urine the same color as that

from the abx!

From Wheldon:

" Chuck Stratton has sent me this study. I believe that metronidazole wasn't

used because it isn't an accepted chlamydicide, and the authors wanted as

few improbables as possible...

There is a great deal in the full-text article which is not covered in the

abstract. For instance, although there was no shrinkage of enhancing lesions

during the period of study, post-study MRIs did show lesion shrinkage in

this group.

The study was meticulous, even to the point of giving the placebo group

riboflavin to give the urine the same colouration as rifampicin. "

Great to see good science.

Jim